Bangkok founders can research bank-backed venture teams, industrial investors, deep-tech specialists and wider Southeast Asian funds. The best starting point is the company’s evidence and the kind of partner it needs. A corporate logo, pilot opportunity and equity round are not the same thing.
Compare 15 provider families, including 10 documented local or regional routes. Start with the decision framework, use the comparison to screen candidates and save the evidence in the worksheet before you approach anyone.
Choose the Bangkok route by evidence and operating fit
| Your situation | Research first | Prepare or clarify |
|---|---|---|
| A post-revenue technology company | Check Beacon’s current criteria and the relevant early/growth funds. | Bring actual customer and revenue evidence rather than an old early-stage description. |
| Industrial, food or agriculture technology | Compare AddVentures, Betagro and appropriate deep-tech investors. | Explain the operating workflow, technical result and independent business model. |
| Health technology ready for a commercial next step | Research Disrupt Health Impact Fund’s specific thesis and entry range. | Prepare product and evidence appropriate to the health use case; training programmes are different. |
| Regional deep tech, enterprise or climate scale-up | Compare SeaX, KXVC, Wavemaker and the relevant ADB Ventures route. | Separate a global mandate, Southeast Asian deployment plan and actual Bangkok office. |
Choose a small first wave you can research properly. Record one reason for fit, one relevant proof point and the next unanswered question for each investor. Move a name out of the active queue when the stage, sector or geographic conditions do not fit.
Compare 15 local and wider investor routes
The connection column distinguishes a documented city or regional route from a wider mandate. It does not imply that every provider has an office here. Initial investment stages and follow-on support are different. This selective list is unranked; each provider family counts once.
| Investor or network | Connection | Entry-stage distinction | Company focus |
|---|---|---|---|
| Beacon VC | Local / regional: Bangkok office; Southeast Asian focus | Post-revenue; published track-record criteria | Financial and technology-enabled businesses |
| SCB 10X | Local / regional: SCBX-linked Thai platform; international investments | Venture; confirm initial round | AI; blockchain; fintech; enterprise technology |
| Krungsri Finnovate | Local / regional: Thai and ASEAN bank ecosystem | Series A and above for Finnoventure; other routes distinct | Technology and financial innovation |
| AddVentures by SCG | Local / regional: Bangkok/SCG industrial ecosystem; global partnerships | Corporate venture; confirm current round | Industrial; B2B; enterprise technology |
| ORZON Ventures | Local / regional: Thai OR ecosystem; Southeast Asia | Growth stage | Mobility; retail; lifestyle; health/wellness; travel |
| Singha Ventures | Local / regional: Thai corporate base; international opportunities | Corporate venture; confirm current entry | Consumer; retail and related technology |
| SeaX Ventures | Local / regional: Bangkok and US offices; global investing | Early stage | Deep technology |
| Expara | Wider route: Southeast Asian investment platform | Early-stage funds; programme-specific | Technology businesses |
| Openspace Capital | Wider route: Southeast Asia-wide | Early and growth; strategy-specific | Tech-native and technology-enabled businesses |
| Vertex Ventures Southeast Asia & India | Wider route: Regional platform; Thailand in covered markets | Venture; confirm current entry | Enterprise; consumer and other technology |
| KXVC | Local / regional: KASIKORN X ecosystem; global-to-Southeast-Asia remit | Seed; Series A and B | AI/ML/data; deep technology; decentralized technology |
| Betagro Ventures | Local / regional: Bangkok/Betagro ecosystem; global mandate | Early stage | Foodtech; agritech; precision-health adjacency |
| Disrupt Health Impact Fund | Local / regional: Thai healthcare ecosystem; global investing | Pre-Series A to Series B | Preventive care; longevity; holistic health; AI-enabled hospitals |
| ADB Ventures | Wider route: Emerging Asia; not a Bangkok office claim | Early-stage venture; SEED support is distinct | Climate and impact-focused technology |
| Wavemaker Ventures | Wider route: Southeast Asia | Early stage | Enterprise; deep technology; sustainability |
Can a pre-revenue startup approach Bangkok’s corporate investors?
Do not assume every corporate venture team invests before revenue. Beacon’s published criteria describe post-revenue companies and generally an operating track record. Krungsri Finnovate’s current site also distinguishes Series-A-and-above investment strategies from acceleration. A programme serving young founders is not evidence that every associated fund writes idea-stage cheques.
If the company is earlier, research an explicitly suitable route and make the stage question your first screen. Explain which evidence exists, which evidence is still missing and what the next round would establish. Keep collected revenue separate from contracts, pilots and sales pipeline.
Pitch an investment and a corporate partnership as two decisions
A Bangkok company may see a useful banking, industrial, food or retail partner in these investor networks. Prepare two short explanations: why the startup is an attractive independent business and what a particular operating collaboration could demonstrate. The buyer, procurement process and investment committee may all differ.
AddVentures by SCG, Betagro Ventures and the bank-linked teams publish different operating propositions. ORZON’s current growth-stage remit also differs from a first-cheque seed fund. Avoid suggesting that corporate equity automatically delivers a customer, distribution contract or pilot.
Use the specialist thesis to narrow a regional shortlist
Disrupt Health Impact Fund describes specific health themes and a pre-Series-A-to-Series-B range. KXVC publishes AI/data and deep-technology areas with a global-to-Southeast-Asia perspective. ADB Ventures’ climate/impact venture route is different again, and its SEED support should be evaluated separately.
The Thailand investor guide remains the wider national overview. This Bangkok selection adds the corporate-versus-independent and evidence-stage decisions. A larger list is useful only when you can explain which lane each name belongs in.
15 investors and networks to research
1. Beacon VC
Corporate VC. Beacon’s current criteria matter more than an old early-stage label: the firm asks for post-revenue companies and generally an operating track record. A Bangkok team should bring actual customer and revenue evidence. Prepare a standalone investment case alongside any potential KASIKORNBANK collaboration.
Approach: Use the relevant Contact founder enquiry. Official Beacon VC information. Additional criteria or geographic context.
2. SCB 10X
Corporate VC. SCB 10X is a specialist technology route connected to the SCBX group. A Bangkok founder should show technical and market fit rather than assume any Thai startup is relevant. Clarify the equity opportunity separately from a potential corporate technology or deployment relationship.
Approach: Use the official investment-team information and contact. Official SCB 10X information.
3. Krungsri Finnovate
Corporate venture platform. Krungsri Finnovate separates venture strategies from early-stage acceleration. Identify the specific vehicle and maturity requirement before approaching the team. A Bangkok company with customers should prepare operating evidence; a prelaunch team should not infer equity eligibility from a training programme.
Approach: Use the current fund/investment route. Official Krungsri Finnovate information.
4. AddVentures by SCG
Corporate VC. AddVentures is useful when a startup addresses a real industrial workflow relevant to SCG. Explain the standalone venture economics and the potential deployment separately. A pilot, partnership and equity investment are different decisions and should not be presented as one promised package.
Approach: Use the published corporate-venture contact. Official AddVentures by SCG information.
5. ORZON Ventures
Growth-stage venture fund. ORZON’s current site describes a growth-stage strategy, supported by OR’s operating ecosystem and 500 Global relationships. Bring commercial traction and the specific distribution or deployment use case. It counts once here; its 500-related operating connections are not additional investors in the total.
Approach: Use the current official contact. Official ORZON Ventures information.
6. Singha Ventures
Corporate VC. Singha’s corporate connections can matter when the product has a clear consumer, retail or operating fit. A Bangkok founder should identify the buyer and standalone growth case before discussing access to the group’s channels. A corporate meeting is not a commitment to distribution or capital.
Approach: Use the official Contact page. Official Singha Ventures information. Additional criteria or geographic context.
7. SeaX Ventures
Deep-tech VC. SeaX can be relevant to a technically differentiated company with a credible Southeast Asian deployment path. Show the defensible technical result and the next commercial or development milestone. Its Bangkok connection does not mean the fund invests only in Thai companies.
Approach: Use the current official investment contact. Official SeaX Ventures information.
8. Expara
Venture capital and venture-building platform. Expara’s venture funds sit alongside acceleration, education and advisory services. Select the investment route when building a Bangkok fundraising queue and confirm current intake. An accelerator, course or consulting engagement should not be counted as an equity commitment.
Approach: Use Contact and identify the venture investment route. Official Expara information. Additional criteria or geographic context.
9. Openspace Capital
Early and growth VC. Openspace’s regional coverage provides an additional lane once the Bangkok company’s actual stage is clear. Choose the early or growth strategy and explain the product, market and commercial evidence. Broad Southeast Asian reach does not make every round or sector suitable.
Approach: Use the relevant team through Contact. Official Openspace Capital information. Additional criteria or geographic context.
10. Vertex Ventures Southeast Asia & India
VC. Vertex SEAI is a wider regional route, not a blanket claim of a Bangkok office. Explain the first market and relevant technology insight, then identify the appropriate team. Keep initial investment criteria separate from later support provided to existing portfolio companies.
Approach: Use Pitch to us. Official Vertex Ventures Southeast Asia & India information. Additional criteria or geographic context.
11. KXVC
Corporate venture firm. KXVC publishes a global founder mandate with Southeast Asian expansion support and seed-to-Series-B stage categories. It deploys its own internal capital, unlike an external investor fundraising product. Select the actual technology thesis and distinguish this investment team from other Kasikorn-linked strategies.
Approach: Use the published startup/firm enquiry. Official KXVC information.
12. Betagro Ventures
Corporate venture firm. Betagro separates venture capital, venture building and partnerships. A Bangkok food or agriculture team should explain the technical and customer evidence and identify which relationship it seeks. The corporate ecosystem may offer useful expertise, but a partnership conversation is not an equity approval.
Approach: Use the current official contact and venture investment information. Official Betagro Ventures information.
13. Disrupt Health Impact Fund
Health-technology venture fund. Disrupt’s published health thesis and pre-Series-A-to-Series-B range provide specific filters. Prepare the health product, evidence and commercial entry plan for Thailand or Southeast Asia. Do not confuse its training courses, corporate innovation work and direct fund investment.
Approach: Use the investment contact published on the fund page. Official Disrupt Health Impact Fund information.
14. ADB Ventures
Development-backed venture platform. ADB Ventures is a wider route for climate and impact solutions with an emerging-Asia scale-up case. Its venture capital and very-early SEED support have different roles. A Bangkok team should identify the relevant programme and document the climate, inclusion and commercial evidence without assuming one set of terms applies to all.
Approach: Use Become our investee for the relevant current route. Official ADB Ventures information.
15. Wavemaker Ventures
Venture firm. Wavemaker’s current Southeast Asian thesis is useful for a Bangkok enterprise, deep-tech or sustainability company. Lead with a meaningful operating problem and the evidence behind the proposed solution. Use the regional investment team rather than assuming a general Wavemaker brand describes every geographic strategy.
Approach: Use the official Contact route. Official Wavemaker Ventures information.
A Bangkok food-technology team separates commercial and capital fit
Fictional worked example. A fictional Bangkok team has a food-processing technology prototype and an authorized trial with one producer. It is seeking capital for validation and commercialization. The trial is not recurring revenue, and the company has no commitment from the trial partner or any investor.
| Candidate | Next action | Why it changes the decision |
|---|---|---|
| Betagro / AddVentures | Investigate only the genuinely relevant operating thesis. | Food, agriculture and industrial workflows differ; the team must explain the actual fit. |
| SeaX / Wavemaker | Research the technical and early-stage venture screen. | The prototype can support a technical discussion without proving commercial scale. |
| Beacon | Resolve the published post-revenue readiness gap first. | A trial should not be relabeled as revenue to fit the criteria. |
| Disrupt Health Impact Fund | Exclude unless there is a genuine health-technology proposition. | A food-industry label alone does not establish the specialist health thesis. |
The aim is a more coherent queue, not the largest possible one. Connect the proposed round with an achievable milestone using the round-size planning worksheet.
Build your Bangkok investor-fit worksheet
Use one card for each provider and strategy. It works in a document, spreadsheet or your Finta research notes. Keep facts, expectations and questions in separate fields.
INVESTOR FIT CARD: BANGKOK
Company, current evidence and next funding milestone: [authorised facts]
Bangkok connection: office / regional team / Thai operating ecosystem / wider mandate
Business evidence: prototype / trial / contracted customer / collected revenue
Relationship sought: equity / commercial pilot / procurement / programme
Specialist lane: bank technology / industrial / food-agri / health / deep tech / climate
Current strategy and related brands: count the provider once
Investor and specific vehicle: [current name; avoid rebrand duplicates]
Official stage, sector and geographic criteria: [URL; date]
Fit evidence: [what matches; not just a portfolio resemblance]
Mismatch or open question: [the unresolved issue]
Approach route: [founder form / network selection / general enquiry]
Relationship context: [known person; permission to ask; or public route]
Lead/co-investment status: [unknown / conditional / confirmed]
Owner, next action and follow-up date: [person; action; date]Bring the shortlist into Finta to keep investor research, relationship context and follow-up connected. Aurora can help organise the context and prepare a next move for your review. You stay in control of the approach and information shared.
Review your shortlist with Aurora, Claude or Codex
Paste the prompt with the public sources and company information you are authorised to use. Check its output against the sources before acting.
Help me research investor fit for a Bangkok startup.
Company, location, current evidence and funding milestone: [authorised facts]
Candidates and official sources: [names, URLs and research dates]
Separate local offices, regional operating requirements and wider investment eligibility.
Check the specific vehicle, initial stage, sector, company conditions and public approach route.
Keep university programmes, angel networks, direct equity, grants and commercial partnerships distinct.
Count each manager or rebrand once. Do not assume a portfolio investment proves current eligibility.
Return a table: source, fit evidence, mismatch, unknown, next question and owner.
Flag missing or contradictory evidence instead of filling gaps.
Suggest a short first research wave and explain exclusions.
Do not contact anyone, submit forms or share confidential information.Keep the wider fundraising process connected with the pre-seed guide, Seed Fundraising Comprehensive Guide and investor-prospecting workflow. For national coverage, see the Thailand investor guide.
Methodology and research date
By Finta Editorial Team. Official investor, public-institution and company materials reviewed November 13, 2026, with source-dated prior research used for discovery. 15 provider families are included: 10 documented local or regional routes and 5 wider mandates. Angel networks are identified as networks, not pooled funds. Company-building and strategic investment routes are labelled separately.
Startup Genome’s 2026 Emerging Ecosystems ranking informed city selection; it is not an investor ranking or endorsement. Current official materials support the profiles. A published thesis is not a promise of available capital, current intake or an investment outcome. Confirm open questions directly.
Not counted or kept separate:
- N-Vest is not counted while current direct official investment evidence and approach details remain insufficient; an association mention alone is not used.
- The unrelated content now served at the old Bualuang Ventures domain is not treated as current investor evidence.
- ORZON’s 500 Global-related operating connections are not counted as additional providers.
General information, not personalised financial, legal or tax advice. Programme and company criteria are research filters, not an eligibility ruling. The cover is an editorial ecosystem illustration, not a map of investor offices or actual financing flows.